HomePDSB • NASDAQ
PDS Biotechnology Corp
add
$1.15
0.00%
After Hours:(0.87%)-0.0100
$1.14
Closed: Sep 18, 7:52:49 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.62M | -12.22% |
Net income | -9.43M | -13.28% |
Net profit margin | — | — |
Earnings per share | -0.21 | 8.70% |
EBITDA | -7.61M | 12.24% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.87M | -44.79% |
Total assets | 40.48M | -33.09% |
Total liabilities | 24.52M | -17.11% |
Total equity | 15.96M | — |
Shares outstanding | 46.63M | — |
Price to book | 3.38 | — |
Return on assets | -43.56% | — |
Return on capital | -50.27% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.43M | -13.28% |
Cash from operations | -9.10M | -2.75% |
Cash from investing | — | — |
Cash from financing | 995.94K | 7,324.31% |
Net change in cash | -8.11M | 8.94% |
Free cash flow | -3.54M | 49.42% |
Previous close
$1.15
Day range
$1.13 - $1.22
Year range
$0.85 - $4.29
Market cap
53.63M USD
Avg Volume
507.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Website
Employees
24
